Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zofenopril + hydrochlorothiazide versus irbesartan + hydrochlorothiazide in elderly patients with isolated systolic hypertension
2010-021988-32Phase 3Completed
- Sponsor
- Istituto Lusofarmaco
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in isolated systolic hypertension (ISH) comparing Zofenopril + hydrochlorothiazide with Irbesartan + hydrochlorothiazide (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2010; status: completed.
02
Drugs
zofenoprilhydrochlorothiazideirbesartan
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on 2010-021988-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021988-32.